There are still lots of open positions. Let's find the one that's right for you.
SAGA Diagnostics is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analysis of circulating tumor DNA (ctDNA). The company's mission is to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services. SAGA's proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at unprecedented sensitivity and scale. The Medical Science Liaison (MSL) in Molecular Residual Disease (MRD) is a highly specialized role focused on advancing the scientific understanding and clinical application of MRD testing in oncology. MRD testing is used to detect the presence of molecular residual disease, which may indicate the persistence of cancer cells after treatment, potentially leading to relapse. The MSL serves as a key scientific expert in this field, providing clinical and scientific support for MRD assays and solutions, fostering relationships with key opinion leaders (KOLs), clinicians, and researchers, and ensuring that MRD testing plays a pivotal role in the management of cancer patients. As the MSL for Molecular Residual Disease, the successful candidate will play a critical role in shaping the clinical adoption and implementation of MRD testing in oncology. They will contribute to the broader mission of improving cancer patient care by offering cutting-edge diagnostic tools that enable earlier detection of disease recurrence and more precise treatment decisions.